These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15515294)
1. Memantine: a new approach to Alzheimer's disease. Keltner NL; Williams B Perspect Psychiatr Care; 2004; 40(3):123-4. PubMed ID: 15515294 [No Abstract] [Full Text] [Related]
2. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date. Bullock R Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232 [TBL] [Abstract][Full Text] [Related]
4. What is the rationale for new treatment strategies in Alzheimer's disease? Rogawski MA CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294 [TBL] [Abstract][Full Text] [Related]
5. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases. Monastero R; Camarda C; Pipia C; Camarda R J Neurol Neurosurg Psychiatry; 2007 May; 78(5):546. PubMed ID: 17030587 [No Abstract] [Full Text] [Related]
7. [Cholesterol inhibitor and memantine in symptomatic dementia therapy]. Rodda J; Carter J Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240 [No Abstract] [Full Text] [Related]
8. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease. Doody R; Wirth Y; Schmitt F; Möbius HJ Dement Geriatr Cogn Disord; 2004; 18(2):227-32. PubMed ID: 15256834 [TBL] [Abstract][Full Text] [Related]
9. Memantine for dementia? Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973 [TBL] [Abstract][Full Text] [Related]
10. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease. Papageorgiou SG; Kontaxis T; Antelli A; Kalfakis N J Clin Psychopharmacol; 2007 Aug; 27(4):407-8. PubMed ID: 17632233 [No Abstract] [Full Text] [Related]
11. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Wilkinson D; Andersen HF Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761 [TBL] [Abstract][Full Text] [Related]
12. Memantine (Ebixa) in clinical practice - results of an observational study. Calabrese P; Essner U; Forstl H Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714 [TBL] [Abstract][Full Text] [Related]
13. Classics in Chemical Neuroscience: Memantine. Alam S; Lingenfelter KS; Bender AM; Lindsley CW ACS Chem Neurosci; 2017 Sep; 8(9):1823-1829. PubMed ID: 28737885 [TBL] [Abstract][Full Text] [Related]
14. Drugs for Alzheimer's disease. Cranwell-Bruce LA Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985 [No Abstract] [Full Text] [Related]
15. Treatment of Alzheimer disease. Winslow BT; Onysko MK; Stob CM; Hazlewood KA Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540 [TBL] [Abstract][Full Text] [Related]
16. Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia. Koch HJ; Uyanik G; Fischer-Barnicol D Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):499-506. PubMed ID: 16266284 [TBL] [Abstract][Full Text] [Related]